PlexBio Company Description

PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects.

It offers workflow navigation services; automated sample preparation extraction kits; IntelliPlex platform that is designed for pCode technology with for sample-to-answer multiplexing assays; oncology kits for lung cancer and mutation detection, as well as rearrangements; IntelliPlex SARS-CoV-2 detection test kits/flu kits and IntelliPlex SARS-CoV-2 variant analysis kits; and pCode coupling buffer sets.

PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan.

PlexBio Co., Ltd.

Country	Taiwan
Founded	2009
Industry	Medical Devices
Sector	Healthcare
CEO	Ting Cao

Contact Details

Address: No. 351, Yangguang Street Taipei, 11491 Taiwan
Phone	886 2 2627 5878
Website	plexbio.com

Stock Details

Ticker Symbol	6572
Exchange	Taipei Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0006572001
SIC Code	2835

Key Executives

Name	Position
Dr. Ting Cao Ph.D.	Chairman, President and Chief Executive Officer
Lipi Yeh	Chief Financial Officer
Erik Hsu	Vice President of Operations and Business Development
Jiahong Hong	Accounting Supervisor
Dr. Chin-Shiou Huang	Vice President and Chief Technology Officer
Huei Te Uwe	Senior Administration Manager
Honggo Chang	Project and Sales Manager